Mid-Term Outcome after Extracorporeal Life Support in Postcardiotomy Cardiogenic Shock: Recovery and Quality of Life
Authors:
- Maja HanunaMHMaja Hanuna
- German HerzGHGerman Herz
- Andre L. StanzlASAndre L. Stanzl
- Yupeng LiYLYupeng Li
- Christoph S. MuellerCMChristoph S. Mueller
- Christine E. KamlaChristine E. Kamla
- Clemens SchererCSClemens Scherer
- Dietmar WassilowskyDWDietmar Wassilowsky
- Gerd JuchemGJGerd Juchem
- Martin OrbanMartin Orban
- Sven PeterssSPSven Peterss
- Christian HaglCHChristian Hagl
Open Access
- 12 April 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (8) , 2254
Abstract
Background: Extracorporeal life support (ECLS) therapy for refractory postcardiotomy cardiogenic shock (rPCS) is associated with high early mortality rates. This study aimed to identify negative predictors of mid-term survival and to assess health-related quality of life (HRQoL) and recovery of the survivors. Methods: Between 2017 and 2020, 142 consecutive patients received ECLS therapy following cardiac surgery. The median age was 66.0 [57.0–73.0] years, 67.6% were male and the median EuroSCORE II was 10.5% [4.2–21.3]. In 48 patients, HRQoL was examined using the 36-Item Short Form Survey (SF-36) and the modified Rankin-Scale (mRS) at a median follow-up time of 2.2 [1.9–3.2] years. Results: Estimated survival rates at 3, 12, 24 and 36 months were 47%, 46%, 43% and 43% (SE: 4%). Multivariable Cox Proportional Hazard regression analysis revealed preoperative EuroSCORE II (p = 0.013), impaired renal function (p = 0.010), cardiopulmonary bypass duration (p = 0.015) and pre-ECLS lactate levels (p = 0.004) as independent predictors of mid-term mortality. At the time of follow-up, 83.3% of the survivors were free of moderate to severe disability (mRS < 3). SF-36 analysis showed a physical component summary of 45.5 ± 10.2 and a mental component summary of 50.6 ± 12.5. Conclusions: Considering the disease to be treated, ECLS for rPCS is associated with acceptable mid-term survival, health-related quality of life and functional status. Preoperative EuroSCORE II, impaired renal function, cardiopulmonary bypass duration and lactate levels prior to ECLS implantation were identified as negative predictors and should be included in the decision-making process.Keywords
This publication has 21 references indexed in Scilit:
- 2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patientsEuropean Journal of Cardio-Thoracic Surgery, 2020
- Multicenter study on postcardiotomy venoarterial extracorporeal membrane oxygenationThe Journal of Thoracic and Cardiovascular Surgery, 2020
- Extracorporeal membrane oxygenation support for postcardiotomy cardiogenic shock in adult patients: predictors of in-hospital mortality and failure to be weaned from extracorporeal membrane oxygenationJournal of Artificial Organs, 2020
- Discriminatory power of scoring systems for outcome prediction in patients with extracorporeal membrane oxygenation following cardiovascular surgery†European Journal of Cardio-Thoracic Surgery, 2019
- Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortalityThe Journal of Thoracic and Cardiovascular Surgery, 2018
- Survival and quality of life after extracorporeal life support for refractory cardiac arrest: A case seriesThe Journal of Thoracic and Cardiovascular Surgery, 2015
- The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: A retrospective observational studyThe Journal of Thoracic and Cardiovascular Surgery, 2015
- EuroSCORE IIEuropean Journal of Cardio-Thoracic Surgery, 2012
- Impact of Chronic Kidney Disease on Patient Outcome following Cardiac SurgeryHeart, Lung and Circulation, 2010
- Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shockThe Journal of Thoracic and Cardiovascular Surgery, 2010